Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women ...

NASA-backed research finds jump training grows cartilage by 26%, protecting astronauts' knees for Mars missions. Could ...

Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...

OsteoStrong®, the global leader in osteogenic loading technology for bone health, proudly announces that a groundbreaking study on its proprietary system has been accepted for publication in The ...

Treatment with romosozumab led to improvements in bone microarchitecture among postmenopausal women with osteoporosis.

GENEVA--(BUSINESS WIRE)--medimaps group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, proudly announces 510(k) clearance from FDA and MDR certification in EU for the ...

Glucocorticoid (GC) treatment of human trabecular meshwork (HTM) cells produces delayed, progressive cellular and extracellular protein/glycoprotein inductions with characteristics matching those ...